T1	Chemical	80 143	anthracycline -based and taxane -based adjuvant chemotherapy is
T2	Phenotype	161 181	2 /neu status , with
T3	Disease	201 231	/neu -positive cancers benefit
T4	Disease	283 306	neu -negative cancers .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	influences	Arg1:T2	Arg2:T1
R3	influences	Arg1:T3	Arg2:T1
R4	isAssociatedWith	Arg1:T3	Arg2:T2
R5	influences	Arg1:T4	Arg2:T1
R6	isAssociatedWith	Arg1:T4	Arg2:T2
